Hepatitis B: all 1,662 studies
Page 8 of 17. Open to participants first (192), then studies with results posted, then the rest; newest registration first within each.
- Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B PatientsCompletedNCT04539652Phase 4
- A Cross-sectional Study for Renal Function of Patients With Chronic Hepatitis B in ChinaStatus unknownNCT04538651
- Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of StudyTerminatedNCT04536532Phase 1/2
- Biomarkers Guided Stopping NAs TreatmentStatus unknownNCT04519359Not applicable
- Plasma Purification and Chronic Hepatitis BStatus unknownNCT04518553Not applicable
- Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B InfectionStatus unknownNCT04507607Early Phase 1
- Healthy Planet Hepatitis BCompletedNCT04503993Not applicable
- The Efficacy and Safety of TAF vs Other NAs in Patients With LVLStatus unknownNCT04501224Not applicable
- Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 TabletsStatus unknownNCT04499443Phase 1
- A Study of ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB SubjectsTerminatedNCT04485663Phase 1
- A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B PatientsStatus unknownNCT04480294Phase 1
- A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on TreatmentCompletedNCT04470388Phase 1
- A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B PatientsCompletedNCT04465890Phase 2
- Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB SubjectsCompletedNCT04464733Phase 1
- HBV Vaccine in Anti-core Positive Donors After LTStatus unknownNCT04442841Phase 2
- Evaluation of Immunoprotection Provided by Hepatitis B Vaccine After Birth in Healthy ChildrenStatus unknownNCT04439435
- Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBVStatus unknownNCT04431375Not applicable
- A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis BCompletedNCT04426968Phase 2
- A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative ResectionStatus unknownNCT04392700Phase 3
- Study on the Tolerance and Pharmacokinetics of GST-HG141 TabletsStatus unknownNCT04386915Phase 1
- Use of Dynavax Heplisav B in Healthcare Workers Previously Vaccinated With 3-dose Vaccine Who Failed to Demonstrate SeroprotectionWithdrawnNCT04385524Not applicable
- HBV/HCV/HIV in Belgian PrisonsCompletedNCT04366492Not applicable
- A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With EntecavirCompletedNCT04365933Phase 2
- Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral InfectionsCompletedNCT04363411Not applicable
- Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst PatientsTerminatedNCT04356404
- Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine ResponseStatus unknownNCT04326803Phase 4
- "Cocktail" Therapy for Hepatitis B Related Hepatocellular CarcinomaStatus unknownNCT04317248Phase 2
- Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy SubjectsCompletedNCT04309526Phase 1
- A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and CirrhosisStatus unknownNCT04301908
- Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old ChildrenCompletedNCT04294433Phase 4
- A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B VaccineCompletedNCT04289987Phase 2
- Evaluation of Novel Point of Care Hepatitis B Diagnostic AssaysWithdrawnNCT04289428
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers.Status unknownNCT04277897Phase 1
- A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABI-H3733 in Healthy AdultsCompletedNCT04271592Phase 1
- Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated CriteriaCompletedNCT04264312
- A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus InfectionCompletedNCT04248426Phase 1
- Chronic HBV Infection in Pregnant Women Taking TAF to Prevent Vertical TransmissionStatus unknownNCT04237376
- Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis BStatus unknownNCT04211805
- Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil MaleateStatus unknownNCT04202536Phase 4
- Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)IdesStatus unknownNCT04201808Phase 4
- Detecting Occult HBV Infection in Liver Donors Positive for Antibody to Hepatitis B Core Antigen (Anti-HBc)Status unknownNCT04199819Not applicable
- Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed PatientsCompletedNCT04199715Phase 1
- Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated CirrhosisStatus unknownNCT04196998Not applicable
- RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLFStatus unknownNCT04195282Not applicable
- Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis bStatus unknownNCT04195074Not applicable
- Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B PatientsStatus unknownNCT04189276Phase 2
- Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & ChildrenCompletedNCT04188223Phase 1
- Metformin as Add-on to the Standard Therapy in Patients With Chronic Hepatitis BCompletedNCT04182321Not applicable
- A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis BStatus unknownNCT04180150Phase 2
- Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, UgandaCompletedNCT04177485Not applicable
- Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B PatientsCompletedNCT04168333Phase 1
- Hepatitis B Vaccine in SeniorsCompletedNCT04162223Early Phase 1
- Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated CirrhosisStatus unknownNCT04160897
- An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis bStatus unknownNCT04157699Phase 2
- An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) TherapyStatus unknownNCT04157257Phase 2
- A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy AdultsCompletedNCT04142762Phase 1
- Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis BStatus unknownNCT04135235
- Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B PatientsStatus unknownNCT04133259Phase 2
- Study on PK of Hydronidone in Patients and Special PopulationCompletedNCT04123769Phase 1
- Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.CompletedNCT04114890Phase 2
- Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple TherapyStatus unknownNCT04113915
- Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B ScreeningCompletedNCT04109625Not applicable
- A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy AdultsCompletedNCT04083716Phase 1
- Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD PatientsCompletedNCT04083157Phase 2/3
- Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg)CompletedNCT04075201Phase 1
- Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy InfantsStatus unknownNCT04073459Phase 2
- Demonstration Project on Health Care Worker Protection Against Hepatitis B in Kalulushi DistrictCompletedNCT04072211Phase 4
- Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis BCompletedNCT04071379Phase 3
- Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B:Status unknownNCT04070079Phase 4
- Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis BStatus unknownNCT04069858Phase 4
- Study of Tenofovir Alafenamide Fumarate Tablets (TAF) in Blocking Mother-to-child Transmission of Hepatitis B VirusStatus unknownNCT04065230
- Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in MadridCompletedNCT04062253
- Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B VirusTerminatedNCT04059198Phase 2
- A Phase IV Study to Assess the Safety of EupentaTM InjStatus unknownNCT04056728Phase 4
- Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral TherapyWithdrawnNCT04046107Phase 1/2
- Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus InfectionWithdrawnNCT04044651Phase 2/3
- Hepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive IndividualsCompletedNCT04038372
- The Clinical Cure Project of Chronic Hepatitis B in ChinaActive, not recruitingNCT04035837Phase 4
- Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT CellsStatus unknownNCT04032392Phase 1
- Correlation Between Virus and Biochemical Characteristics and Liver Histological Damage in Untreated Chronic HBV InfectionCompletedNCT04032275
- Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned InterventionStatus unknownNCT04030039
- Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization ScheduleCompletedNCT04029454Not applicable
- Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis BCompletedNCT04028856
- Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC InhibitorTerminatedNCT04023721Phase 2
- A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)CompletedNCT04008004Phase 1
- Sexual and Reproductive Health (Including PrEP and HBV) for Female Sex Workers in Côte d'IvoireStatus unknownNCT03985085Not applicable
- Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child TransmissionCompletedNCT03977987
- Prediction Model Based on Computed Tomography Liver Volume for the Short-term Mortality in Hepatitis B Related Acute-on-ChronicCompletedNCT03977857
- Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PDStatus unknownNCT03973502Not applicable
- Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis PatientsStatus unknownNCT03969017Phase 2
- Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease PopulationStatus unknownNCT03962881Phase 4
- Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment PatientsStatus unknownNCT03962816Phase 4
- Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected PatientsStatus unknownNCT03962803Phase 4
- Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver FibrosisStatus unknownNCT03957629Not applicable
- Clinical Study on the Effect of IVF-ET on Mother-to-child Transmission of Hepatitis B VirusStatus unknownNCT03932851
- Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B PatientsTerminatedNCT03932513Phase 2
- The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 WeeksCompletedNCT03931239Not applicable
- Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver FibrosisStatus unknownNCT03920605Not applicable
- Protectivity and Safety Following Recombinant Hepatitis B VaccineCompletedNCT03919578Phase 2/3
- Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver FibrosisStatus unknownNCT03919565Not applicable